References
- Greer ND. Voriconazole: the newest triazole antifungal agent. BUMC Proc 2003;16:241–8.
- Bartroli J, Turmo E, Alguero M, Boncompte E, Vericat ML, Conte L, et al. New azole antifungals. 2. Synthesis and antifungal activity of heterocycle carboxamide derivatives of 3-amino-2-aryl-1-azolyl-2-butanol. J Med Chem 1998;41:1855–68.
- Bartroli J, Turmo E, Alguero M, Boncompte E, Vericat ML, Conte L, et al. New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones. J Med Chem 1998;41:1869–82.
- Upadhayaya RS, Sinha N, Jain S, Kishore N, Chandra R, Arora SK. Optically active antifungal azoles: synthesis and antifungal activity of (2R,3S)-2-(2,4-difluorophenyl)-3-(5-(2-(4-aryl-piperazin-1-yl)ethyl)tetrazol-2-yl/1-yl)-butan-2-ol. Bioorg Med Chem 2004;12:2225–38.
- Foroumadi A, Mirzaei M, Shafie A. Antituberculosis agents II. Evaluation of in vitro antituberculosis activity and cytotoxicity of some 2-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole derivatives. Farmaco 2001;56:621–3.
- Doğan HN, Duran A, Rollas S, Sener G, Uysal MK, Gülen D. Synthesis of new 2,5-disubstituted-1,3,4-thiadiazoles and preliminary evaluation of anticonvulsant and antimicrobial activities. Bioorg Med Chem 2002;10:2893–8.
- Nasr MN, Gineinah MM, El-Bendary ER. Synthesis and in vitro antibacterial evaluation of novel imidazo[2’,1’:5,1]-1,2,4-triazolo[4, 3-c]-quinazoline derivatives of 5-thioxo-1, 2, 4-triazole, 4-oxothiazolidine, and their open-chain counterparts. Arch Pharm Pharm Med Chem 2003;336:560–6.
- Doğan HN, Rollas S, Erdeniz H. Synthesis, structure elucidation and antimicrobial activity of some 3-hydroxy-2-naphthoic acid hydrazide derivatives. Farmaco 1998;53:462–7.
- Modzelewska-Banachiewicz B, Matysiak J, Niewiadomy A. Synthesis and mycological activity of the compounds obtained in the reaction of N3-substituted amidrazones with sulphinyl-bis-2,4-dihydroxybenzenethioyl. Eur J Med Chem 2001;36:75–80.
- Ergenç N, Ulusoy N, Çapan G, Sanış GÖ, Kiraz M. Synthesis and antimicrobial properties of new 4-(alkylidene/arylidene)- amino-5-(2-furanyl)-2,4-dihydro-3H-1,2,4-triazole-3-thiones and 6-aryl-3-(2-furanyl)-7H-1,2,4-triazolo[3,4-b][1,3,4]thiadiazines. Arch Pharm Pharm Med Chem 1996;329:427–30.
- Karalı N, Çapan G, Ergenç N, Gürsoy A. Synthesis, characterization and preliminary anticonvulsant evaluation of new indoline-2,3-dione derivatives. Sci Pharm 1997;65:277–87.
- Ulusoy N, Çapan G, Ergenç N, Ekinci AC, Vidin A. Synthesis, characterization and anticonvulsant activity of new 4-thiazolidinone and 1,2,4-triazole-3-thione derivatives. Acta Pharm Turc 1998;40:5–8.
- Terzioğlu N, Karalı N, Gürsoy A, ötük G, Kiraz M, Erturan Z. Synthesis and antimicrobial activity of new triazole and thiadiazole derivatives of 4(3H)-quinazolinones. Acta Pharm Turc 1998;40:77–82.
- Ulusoy N, Gürsoy A, ötük G. Synthesis and antimicrobial activity of some 1,2,4-triazole-3-mercaptoacetic acid derivatives. Farmaco 2001;56:947–52.
- Terzioğlu N, Gürsoy A. Synthesis and anticancer evaluation of some new hydrazone derivatives of 2,6-dimethylimidazo[2,1-b][1,3,4]thiadiazole-5-carbohydrazide. Eur J Med Chem 2003;38:781–6.
- Çapan G, Ergenç N, Ötük G. Synthesis and biological evaluation of 4-alkyl/aryl-1-(2-furoil)-3-thiosemicarbazides and 4-alkyl/aryl-2,4-dihydro-5-(2-furyl)-3H-1,2,4-triazole-3-thiones. J Fac Pharm İstanbul 1990–92;26–8:23–9.
- National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts. M27-A. Villanova, PA: NCCLS, 1997.
- National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentousa fungi; proposed standard. M38-P. Villanova, PA: NCCLS, 1998.
- Rodríguez-Tudela JL, Berenguer J, Martínez-Suárez JV, Sanchez R. Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans. Antimicrob Agents Chemother 1996;40:1998–2003.
- Fernandez-Torres B, Cabanes FJ, Carillo-Munoz A, Esteban A, Inza I, Abarca L, et al. Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol 2002;40:3999–4003.
- Gürsoy A, Karalı N. Synthesis and anticonvulsant activity of new acylthiosemicarbazides and thiazolidones. Farmaco 1995;50:857–66.
- Temple C. Alkyl or Aryl 1,2,4-Triazoline-5-thiones. In: Weisberger A, Taylor EC, eds. The Chemistry of Heterocyclic Compounds, Vol.37, John Wiley & Sons Inc; New York; 1981:402–4.